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BackgrounD AND OBJECTIVES: Although uterine stenting is performed routinely following hysteroscopic
metroplasty, we were unable to find any evidence documenting its value with regards to septum reformation
and/or obstetrical performance. To evaluate the benefits of intrauterine Foley catheter/balloon splinting after
resectoscopic septum division on septum reformation, fertility, and pregnancy outcomes.
Design AND SETTING: Prospective, randomized controlled pilot study (Canadian Task Force Classification I)
conducted in university affiliated teaching hospital.
Patients AND METHODS: Twenty-eight women with infertility and/or adverse pregnancy outcomes diagnosed
with intrauterine septum were randomized into having a No. 14 pediatric Foley catheter/balloon for 5 days
(n=13) vs. no balloon (n=15) following resectoscopic septum division. None of the patients received preoperative endometrial thinning, antibiotic prophylaxis or adjuvant postoperative hormone therapy. All uterine septa
were divided under general anaesthesia using a 26 F (9 mm) resectoscope with a monopolar electrical knife
using glycine irrigant solution (1.5%) and 120 watts of power of low voltage (cut) waveform.
Results: The median age (range) was 29 years (23-38) and 32 years (22-40), respectively (P=.59). The groups
were comparable by age, past obstetrical performance and comorbidities including endometriosis stage I-IV in
3 and 4 women, in the catheter/balloon and balloon group, respectively, and one in each group of polycystic
ovarian syndrome and Crohn disease and one case of tubal obstruction in the balloon group. There were no
intra- or postoperative complications. At 3 months, a hysterosalpingogram was done in 10 (77%) and 13 (87%)
women, respectively, the results of which were normal. At 12-18 months, 1 woman in the balloon and 3 in the
control group were not trying to conceive and 1 in each group had not conceived. Of the remaining women,
11 (92%) in each group had conceived and pregnancy outcomes included spontaneous abortion 3 (25%) and
4 (33.3%), ectopic pregnancy 0 and 1, second trimester loss 1 (8.3%) and 0 and term pregnancy 8 (66.6%) in
both groups. Conception through assisted reproductive technology occurred in 2 and 1 woman, respectively.
Conclusions: Following resectoscopic septum division with monopolar knife electrode, splinting the uterine cavity with Foley catheter provided no advantage in septum reformation, clinical pregnancy rate, and pregnancy outcomes.
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A

systematic review up to March 2011 of 94 observational studies comprising 89,861 women,
reported a prevalence of congenital uterine
anomalies of 5.5% (95% CI, 3.5%-8.5%) in the unselected population, 8.0% (95% CI, 5.3%-12.0%) in
infertile women, 13.3% (95% CI, 8.9%-20.0%) in those
with a history of miscarriages, and 24.5% (95% CI,
18.3%-32.8%) in those with a history of miscarriages
and infertility. Arcuate uterus is the most common
anomaly in the unselected population (3.9%; 95% CI,
2.1%-7.1%) and its prevalence is not increased in highrisk groups. In contrast, septate uterus is the most common anomaly in high-risk populations1 with a prevalence of 1.1% in the general/fertile population and 3.9%
in women with infertility.2
Septate uterus, resulting from failure of apoptotic
resorption of the medial segment of the Müllerian
ducts, is the most common congenital uterine anomaly,
accounting for approximately 35% of all uterine anomalies,3 and is associated with the highest incidence of
reproductive failure and adverse obstetrical complications when compared with other uterine anomalies. As
a rule, septate uterus affects reproductive health by impairing fertility, and increasing spontaneous abortions
and adverse pregnancy outcomes.4,5 Adverse pregnancy
outcomes include recurrent abortions of the first and
second trimester, intrauterine growth restriction, abnormal placentation, fetal malpresentation, premature
delivery, and an increased risk of Caesarian delivery.6
The mechanism by which a uterine septum causes
these adverse effects remains speculative. Theories include an excessive amount of fibroelastic tissue and a
decreased blood supply to the septum which may adversely affect placentation,7-10 but these findings remain
controversial.11 The diagnosis of septate uterus is made
by a variety of imaging techniques or by direct endoscopic visualization. Hysterosalpingography (HSG)
and/or two dimensional ultrasound (2D US) may be
used as initial screening tools,12 but contrast infusion
sonography (saline infusion sonography or gel infusion
sonography) and 3D US are more accurate for a definitive diagnosis.12-15 MRI has been reported to detect
100% of septate uteri, but because it is time consuming and expensive, its routine use in clinical practice
remains controversial.12,13,16 Combined laparoscopic
and hysteroscopic examination is considered the gold
standard for assessing congenital uterine anomalies,
establishing a correct diagnosis and possibly applying
the principle of ‘see and treat’.13 Laparoscopy is recommended to complete the evaluation of patients with infertility, including assessment and possible concomitant
treatment of tubal disease and/or other conditions in-
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cluding endometriosis. Laparoscopy also differentiates
between a septate and a bicornuate uterus and may be
of value in aspirating excessive intra-abdominal irrigant
fluid and be more safe during hysteroscopic metroplasy.
The only situation in which it may be unnecessary is
when the patient has undergone a previous laparoscopic
evaluation. The main indications to treat a septate uterus are recurrent pregnancy loss and unexplained infertility in the presence of a uterine septum. Hysteroscopic
metroplasty (septum incision) over laparotomic transfundal correction is presently considered the standard
of care.6,17-19
This minimally invasive approach offers many advantages, including outpatient surgery with or without
anaesthesia/analgesia,20 a reduced risk of intra- and
postoperative morbidity, no risk of postoperative pelvic
adhesions, and an increased rate of vaginal delivery.21
Following hysteroscopic metroplasty, by any method,
the incidence of a residual septum (>1 cm) was reported between 0% and 36%.22-24 To minimize the risk of
septum recurrence, it was standard practice to splint the
uterine cavity with an intrauterine device (IUD) for one
month or a Foley catheter, and even shaped balloons,
for 72 hours postoperatively hoping to prevent the incised septum edges from fusing; then start the patient
on estrogen to stimulate endometrial lining growth
over the denuded incised septum area. Although we
had adopted and used all of the above measures including antibiotic prophylaxis, intrauterine Foley balloon,
and postoperative estrogen,25 this standard practice is
not supported by evidence. We have found no studies
describing their benefit on septum reformation and/or
obstetrical performance. Therefore, the objective of this
study was to evaluate the value of an intrauterine Foley
catheter alone following resectoscopic uterine septum
division on the rate of septum reformation, fertility, and
pregnancy outcomes.

PATIENTS AND METHODS
Women with infertility and/or adverse pregnancy outcomes diagnosed with intrauterine septum by HSG,
sonohysterography and/for hysteroscopy, were evaluated by the senior author (GAV) and invited to participate in the study. After ethics approval and informed
consent, 28 women were randomized in the operating
room into having a No. 14 pediatric Foley catheter/
balloon for 5 days (n=13) versus no catheter/balloon (n=15) following resectoscopic septum division.
The Foley balloon was inflated with 5 mL of normal
saline solution. Randomization was based on a computer generated list of numbers (unconcealed). None
of the patients received preoperative endometrial thin-
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ning, antibiotic prophylaxis or adjuvant postoperative
hormone therapy. All patients had general anaesthesia
and concomitant laparoscopy and treatment of pelvic
pathology including adhesiolysis and/or reduction/
excision of endometriosis when indicated using a CO2
laser and/or electrosurgery. The cervix was dialated to
10 mm and all uterine septa were divided using a 26
French (9 mm diameter) resectoscope and 300 lens
(Karl Storz, Tüttlingen, Germany) with a monopolar
electrode utilizing (1.5%) glycine irrigant solution via
an electronic fluid-management system (Endomat, Karl
Storz, Tüttlingen, Germany) and 120 watts of low voltage (cut) waveform delivered by an ICC 350 Erbe electrosurgical unit (Erbe, Tüttlingen, Germany).There was
no specific timing to perform the surgery with regards
to the menstrual cycle.
Resectoscopic metroplasty was carried out using a
Collin (Karl Storz, Tuttlingen, Germany) monopolar
knife electrode at 90 degrees. After visualization of
both uterine cavities and tubal ostia, the division was
started at the apex of the septum and continued towards the fundus with a progressive horizontal incision
in the midline, equidistant from the anterior and posterior wall. Septum division was terminated when both
tubal ostia could be viewed simultaneously, the resectoscope could be moved freely from one cornual recess
to the other without intervening obstruction, or when
significant bleeding was observed signifying that the
incision had reached normal myometrium, even when
anatomic perfection had not been achieved. All procedures were carried out by the two senior authors (BA,
GAV) and all metroplasties were completed within 5 to
10 minutes. All patients were discharged the same day
and the patients with the Foley catheter/balloon were
instructed to cut with scissors the end of the catheter
at 5 days at home and remove the catheter themselves.
They were also instructed to avoid pregnancy until their
first assessment in 3 months by HSG and they were
reassessed at 6 and 12 to 18 months for pregnancy outcomes.
Data were analyzed using SAS software (SAS
Institute, Inc., Cary, NC), with the t test or Wilcoxon
signed-rank test for interval data and chi-square analysis for comparison of nominal data. A P value of <.05
was considered statistically significant.

RESULTS
The median (range) of the patient demographics, obstetrical history and comorbidities are shown in Table 1,
while the intraoperative estimation of the relative septal
length is shown in Table 2. Both tables indicate that the
two groups were comparable. There were no complica-
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Table 1. Median and (range) of patient demographics, obstetrical
history and comorbidities randomized Into Foley balloon versus
no balloon.
Parameter

Balloon
(n=13)

No balloon
(n=15)

P

Age (years)

29 (23 - 38)

32 ( 22-40)

.59

Term delivery

2

2

.94

Preterm delivery

1

3

.33

Second trimester
loss

1

1

.96

One

2

3

.69

Two

4

5

.79

Three

2

2

.94

> Three

0

2

.16

Infertility

3

2

.69

Stage 1

1

2

NS

Stage 2

0

0

NS

Stage 3

1

0

NS

Stage 4

1

2

NS

Crohn’s disease

1

0

NS

PCOS

1

1

NS

Tubal blockage

1

0

NS

Parity

First trimester loss

Comorbidities
Endometriosis

PCOS: Polycystic ovary syndrome

Table 2. Intraoperative estimation of the relative septal length
among the two groups.
Foley balloon
(n=13)

No balloon
(n=15)

P

1/3

4

4

.91

1/2

2

2

.94

2/3

4

3

.6

3

6

.29

From fundus

	Complete

tions intraoperatively or in the immediate postoperative
period. Results of HSG three months post-metroplasty
are shown in Table 3. We could not be certain that the
<1 cm septum, reported by the radiologist, in the balloon group was a recurrence or incomplete division at
the time of metroplasty but in the intention-to-treat
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Table 3. Hysterosalpingogram 3 months following metroplasty
(intention to treat analysis).

Not done
(refused)
Normal
Septum <1 cm

Balloon
(n=13)

No balloon
(n=15)

P

3

2

NS

9 (69%)

13 (87%)

NS

1

0

NS

Table 4. Pregnancy outcome 12 months following metroplasty.
Balloon
(n=13)

No balloon
(n=15)

P

First trimester
loss

3

4

NS

Second trimester
loss

1

0

NS

Preterm delivery

0

0

NS

Term delivery

8

8

NS

Ectopic

0

1

NS

Currently
pregnant

0

3
2 at 8 weeks
1 at 22 weeks

Not trying

1

3

No conception

1

1

Conceived with
ART

2

1

ART: Assisted reproductive technology

(ITT) analysis we considered this cavity as normal. The
patient did conceive and had a term delivery. The rates
of normal uterine cavity by ITT analysis were 77% and
87% in the Foley balloon and no balloon groups respectively (NS), and 100% in both groups if only the known
HSG are included. Fertility and pregnancy outcome at
12 to 18 months postmetroplasty are shown in Table
4. The rates of first trimester loss in the balloon versus
no balloon group were 25% and 33%, respectively, while
the term delivery rate was 66.7% in both groups (NS).

DISCUSSION
There is limited evidence and a lack of consensus on
the postoperative management of hysteroscopic septum division. For example, there no evidence to support
routine preoperative endometrial thinning. One study
randomized women into receiving danazol 600 mg/d
for 2 to 4 weeks (n=15) or luprolide acetate depot 3.75
mg for 2 months (n=15) prior to hysteroscopic metroplasty. Metroplasty was simpler overall in the dan-
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azol group and also faster in introducing the resectoscope. The authors concluded that short preoperative
preparation with danazol results in favorable operating
conditions at limited costs with minimal side effects.26
However, most authors do not consider it essential and
recommend that hysteroscopic metroplasty be scheduled in the early proliferative phase of the cycle. Two
circumstances that may merit preoperative endometrial
thinning to facilitate visualization include a complete or
a wide septum with narrow uterine cavities.
Many surgeons practice and advocate routine use
of antibiotic prophylaxis during hysteroscopic metroplasty. However, a beneficial role for routine antibiotic
therapy during hysteroscopy has not been firmly established. In one study of 2116 hysteroscopic surgical procedures over a 10-year period, where urinary catheters
and antibiotics were not used, there were 30 (1.4%) infections, 18 endometritis and 10 of the urinary tract.
There were no infections in 90 women who had septum
division.27 Furthermore, in a study of 631 women who
underwent routine diagnostic hysteroscopy, antibiotic
prophylaxis was prescribed to 266 women while 365
women underwent the procedure without prophylaxis,
only one infection, adnexitis, that occurred among the
266 (0.38%) who had taken antibiotics.28 Both studies
indicate that during hysteroscopy, antibiotic prophylaxis was not indicated.
Following hysteroscopic septum division, the incidence of a residual septum (>1 cm) is 0-36% and
may impair fertility and pregnancy outcomes,22-24 but
a residual uterine septum of less than 1 cm after hysteroscopic metroplasty does not impair reproductive
outcome.29 Septum division leaves significant mirror
image areas of denuded myometrium in the anterior
and posterior walls, which are eventually epithelialized.
One study reported on hysteroscopy with multiple biopsies at different intervals after hysteroscopic septal
incision in 19 women. Seven days after surgery the sectioned areas were very evident and not epithelialized.
At 14 days, the incised zone was depressed with scattered epithelialization and at one month, the sectioned
surfaces were still depressed and uniformly covered by
thin endometrium. At two months, the uterine cavity
was almost normal with a minimal tendency to central
fundal adhesions. The authors concluded that there is
probably no reason to delay attempts at pregnancy for
longer than two cycles after surgery.30
Attempts to epithelialize the denuded septal surface
more rapidly have been made with the use of exogenous
estrogen. One study in the 1980s recommended estrogen but no IUDs after hysteroscopic metroplasty.31
However, a prospective randomized trial that evaluated
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with HSG, one month postoperatively, the use of estrogen alone (n=23) versus no estrogen (n=23) concluded
that estrogen has no apparent role after hysteroscopic
incision of the septum.32
In the natural state of a collapsed uterine cavity, the
opposing areas of a divided septum touch each other,
raising the concern of agglutination and reformation
of the septum or intrauterine adhesions resulting in
Asherman syndrome. To prevent this, many surgeons
have advocated the use of temporary splints such as
IUDs33-37 to maintain the uterine cavity distended and/
or estrogen to epithelialize the denuded endometrial
cavity rapidly.5,35-37 The role of IUD plus conjugated
estrogen for 30 days (n=10) was compared to no postoperative treatment (n=10). The authors concluded
that IUD insertion and hormonal therapy after hysteroscopic metroplasty do not seem to be needed to
prevent septal fusion.33,38 A retrospective review of 17
patients also concluded that neither an IUD nor estrogen treatment had any effect on intrauterine adhesion
formation.39
Another retrospective study reported term delivery
rates, at 21 months post-hysteroscopic metroplasty of
53.3%, 64.4%, and 88.9% in infertile women who had
received estrogen plus IUD (n=22), estrogen alone
(n=13), and no treatment (n=17), respectively. The authors concluded that a postoperative 3-month estrogen
plus IUD insertion or estrogen alone after hysteroscopic metroplasty are not necessary.35
Finally, a recent study allocated 100 women undergoing hysteroscopic metroplasty into receiving no
treatment (n=25), IUD (Cu 250, n=25), estrogen +
progestin (2 mg estradiol valerate + 0.5mg norgestrel
for 2 weeks, n=25), IUD + estrogen (n=25). All patients were given antibiotic prophylaxis. At second-look
hysteroscopy, adhesions were noted in 1/19 (5.3%) of
the untreated, 3/25 (12%) of IUD + hormones, 2/19
(10.5%) of IUD only, and 0% in the hormone only
group. The authors concluded that neither IUD placement, nor estrogen treatment, nor both, were found to
prevent adhesions or facilitate pregnancy after hysteroscopic uterine septum resection.36
Originally then, both measures were thought necessary to prevent fusion of the fresh divided septum
and intrauterine adhesion formation or septum reformation.31,37 However, current literature suggests that
splints and hormonal therapy are not necessary.32,36-38
Although the use of intrauterine balloons for 5 to
7 days has been advocated, we found no studies to describe a risk-benefit analysis. To our knowledge, this
is the first randomized comparison of a Foley balloon
versus no balloon following hysteroscopic metroplasty.
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Since we found no benefits, and since there may be potential adverse events associated with routine use of
Foley intrauterine balloons, at this time, we cannot recommend its routine use in clinical practice. Potentially,
uterine rupture can occur because of intrauterine expansion of Foley balloon after hysteroscopic metroplasty. Indeed a case of uterine rupture and intraperitoneal
bleeding presumably related to the pressure of the intrauterine Foley balloon five hours after hysteroscopic lysis
of adhesions has been reported.40
Routine second look hysteroscopy and break down
of adhesions has been advocated by some investigators.5
This practice however remains controversial in view
of the failure in detecting adhesions in a series of 29
patients undergoing diagnostic hysteroscopy 2 months
after surgery.34
Table 1 indicates that pelvic pathology may co-exist
in women with infertility and uterine septum. For this
reason, in women with septate uterus who had no laparoscopy as part of their routine evaluation of infertility, we advocate concomitant laparoscopy at the time of
metroplasty. At least two studies reported significantly
higher prevalence of endometriosis in patients with
Müllerian anomalies compared to controls, but no difference between non-obstructive anomalies and controls.41-42 Futhermore, a retrospective evaluation of 120
women with septate uterus compared to 486 consecutive infertile women with non-septate uterus found endometriosis in 25.8% and 15.2% of women, respectively
(P<.006).43
The underlying mechanism by which the presence of
septi impairs fertility remains speculative. Using scanning electron microscopy, a study demonstrated significant ultrastructural alterations in septal endometrium
compared with endometrium from the lateral uterine wall in samples obtained during the preovulatory
phase.44 These ultrastructural changes may result in impaired sensitivity or receptivity associated with alterations of homeobox cluster A (HOXA-10) implantation
genes decreasing sensitivity or receptivity of the endometrium covering the septum. This mechanism may be
similar to that exerted by the presence of submucosal/
intramural myomas45 and/or endometrial polyps46 in
impairing implantation. Recent evidence indicates that
in the presence of submucous and intramural myomas
there is a global reduction in endometrial HOX gene
expression which may impair receptivity of the entire
endometrium.45,46
The strength of our study is that it is a randomized
controlled trial comparing a single variable, the use of
Foley balloon on septum reformation, determined by
an objective method, HSG, and clinical outcomes in-
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cluding fertility and pregnancy outcomes. Limitations
of the study include heterogeneity and small number of
enrolled subjects with insufficient power to determine
significant differences between the two groups.
Following resectoscopic septum division with monopolar knife electrode, splinting the uterine cavity
with a Foley catheter provided no advantage in septum
reformation, clinical pregnancy rate, and pregnancy

outcomes. Our results on clinical outcomes, including
fertility and reproduction, are in keeping with those reported by previous observational studies; a reduction in
miscarriage rate from 88% to 14% and an increase in
live birth rate from 3% to 80% after metroplasty.5,13,47
However, the need remains for larger randomized controlled trials to address the effectiveness and safety of
adjunct therapy with hysteroscopic metroplasty.
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